capsule applicator News
-
Atmo exhibits at Australian Gastroenterology Week
Atmo Biosciences exhibited at Australian Gastroenterology Week Conference in Adelaide thanks to the generous support of C.R. Kennedy. CEO Mal Hebblewhite reported plenty of interest from gastroenterologists regarding the two clinical trials Atmo recently commenced with Professor Peter Gibson at Monash University. There was also lots of discussion about using the Atmo Gas Capsule as a research ...
-
ANX ROBOTICA CORP RECEIVES 510(K) CLEARANCE FROM FDA TO MARKET ITS INTRAMARX™ RADIOPAQUE MARKERS
AnX Robotica Corp receives 510(k) clearance from FDA to market its IntraMarX™ Radiopaque Markers Plano, TX March 31st, 2020 – AnX Robotica Corp (AnX) today announced that it has received FDA 510(k) clearance to market its IntraMarX™ Radiopaque Markers (ROM). Radiopaque markers are used to measure colon transit time and they are the most basic and primary tool in evaluating ...
By AnX Robotica
-
Regor announces China NMPA approval of the IND for RGT-419B capsule, a CDK2/4/6 inhibitor for advanced/metastatic breast cancer
Regor Therapeutics Group announced that the investigational new drug (IND) application of RGT-419B capsule, a CDK2/4/6 small molecule inhibitor, had been approved by the National Medical Products Administration (NMPA) of China. A Phase I clinical study will be conducted in Chinese patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you